Genetic interaction between the non‐homologous end joining factors during B and T lymphocyte development: in vivo mouse models by Castaneda Zegarra, Sergio Miguel et al.
Scand J Immunol. 2020;92:e12936.    |  1 of 9
https://doi.org/10.1111/sji.12936
wileyonlinelibrary.com/journal/sji
1 |  INTRODUCTION
DNA double-strand breaks (DSBs) are generated both ex-
trinsically, for example, by chemotherapeutic agents, and 
physiologically, for example, during V(D)J recombination in 
developing B and T lymphocytes, and class switch recombi-
nation (CSR) in activated mature B cells.1,2
The DNA damage response (DDR) pathway is initiated 
upon the induction of DSBs. Ataxia telangiectasia mutated 
(ATM) is a DDR regulator protein kinase that phosphorylates 
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Abstract
Non-homologous end joining (NHEJ) is the main DNA repair mechanism for the 
repair of double-strand breaks (DSBs) throughout the course of the cell cycle. DSBs 
are generated in developing B and T lymphocytes during V(D)J recombination to 
increase the repertoire of B and T cell receptors. DSBs are also generated during 
the class switch recombination (CSR) process in mature B lymphocytes, providing 
distinct effector functions of antibody heavy chain constant regions. Thus, NHEJ is 
important for both V(D)J recombination and CSR. NHEJ comprises core Ku70 and 
Ku80 subunits that form the Ku heterodimer, which binds DSBs and promotes the 
recruitment of accessory factors (e.g., DNA-PKcs, Artemis, PAXX, MRI) and down-
stream core factors (XLF, Lig4 and XRCC4). In recent decades, new NHEJ proteins 
have been reported, increasing complexity of this molecular pathway. Numerous in 
vivo mouse models have been generated and characterized to identify the interplay of 
NHEJ factors and their role in development of adaptive immune system. This review 
summarizes the currently available mouse models lacking one or several NHEJ fac-
tors, with a particular focus on early B cell development. We also underline genetic 
interactions and redundancy in the NHEJ pathway in mice.
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multiple substrates in response to the DSBs, including histone 
H2AX, modulator of DNA damage checkpoint 1 (MDC1) and 
p53-binding protein 1 (53BP1). Phosphorylated H2AX facil-
itates the recruitment of MDC1, following the activation of 
Really Interesting New Gene (RING) Finger Protein 8 (RNF8) 
and RNF168, which are ubiquitin ligases. Phosphorylated and 
ubiquitinated H2AX facilitates recruitment of 53BP1, which in 
turn mediates recruitment of RIF1 and interacts with Rev7. The 
Shieldin complex also promotes DNA repair.1,3 Accumulation 
of DSBs results in ATM-dependent activation of checkpoint ki-
nases 1 and 2 (CHK1 and CHK2), which arrests the cell cycle, 
followed by phosphorylation and stabilization of p53, which 
triggers apoptosis.4
In mammalian cells, the non-homologous end-joining 
(NHEJ) pathway repairs the majority of DSBs.5-7 There are 
evolutionary conserved NHEJ factors referred to as ‘core’ 
factors, as well as accessory factors that may be dispensable 
for DNA repair in wild-type cells. Ku70, Ku80, X-ray re-
pair cross-complementing protein 4 (XRCC4), DNA ligase 
4 (Lig4) and XRCC4-like factor (XLF) are core factors,8-12 
while DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs),13-16 Artemis nuclease,17 paralogue of XRCC4 
and XLF (PAXX),18-21 and modulator of retroviral infection 
(MRI)22,23 are usually considered accessory factors.
During the last years, several models have been proposed to 
explain how the two free DNA ends are brought back together 
through synapsis. In particular, Loparo’s group7 suggested a 
two-stage model of NHEJ synaptic complex assembly, where 
DNA ends are initially tied in a long-range complex, followed 
by transition into a short-range complex. In this model, Ku70, 
Ku80 and DNA-PKcs (DNA-PK) first participate in the for-
mation of the initial long-range complex, where DNA ends 
are held sufficiently distant. Then, the short-range complex is 
formed by DNA-PK, XLF, Lig4 and XRCC4. PAXX and MRI 
have not been implicated in this model because their functions 
have not been identified.7 Another model proposed by Lieber’s 
group24 suggests that there are two major structural complexes 
formed during the NHEJ synapsis. Ku70, Ku80, XRCC4 and 
Lig4 form the flexible synaptic (FS) complex, where XRCC4 
and Lig4 bind to each DSB through interaction of Lig4 with Ku 
heterodimer. Subsequently, DSBs are brought together through 
interaction of XRCC4, giving rise to two Ku-XRCC4-Lig4-
DNA complexes. XLF and PAXX both promote transition from 
FS to the second synaptic complex, called close synapsis (CS), 
although XLF stabilizes CS to a greater extent. XLF stimulates 
and impacts the general synapsis efficiency mediated by Ku-
XRCC4-Lig4. It is suggested that DNA-PKcs is not required for 
the formation of either FS or CS. This latter model explains the 
evolutionarily central synaptic role of the core NHEJ factors, 
Ku70, Ku80, XRCC4, Lig4 and XLF.24
For practical purposes, NHEJ can be divided into three 
major stages: DSB recognition, stabilization-processing 
and end ligation.25 Initially, DSBs are recognized by the 
heterodimer Ku, which is formed by Ku70 and Ku80. Ku 
assists the recruitment of DNA-PKcs,13-16 forming the 
DNA-PK holoenzyme. Subsequently, Artemis nuclease,17 
PAXX18-21 and MRI22,23 are recruited to the DSB sites. 
Finally, XLF, XRCC4 and Lig4 mediate the Ku-dependent 
DNA end ligation.1
During the early stages of B and T cell development, NHEJ 
is required for the V(D)J recombination assembling immuno-
globulin (Ig) and T cell receptor (TCR) genes using V, D and 
J gene segments. Both Ig and TCR provide antigen-binding 
specificity required for an efficient immune response. The 
proteins encoded by the recombination activating genes 1 and 
2 (RAG1,2) form an endonuclease (RAG) that recognizes re-
combination signal sequences (RSSs) flanking the V, D and 
J gene segments.26
Class switch recombination takes place in mature B cells, 
when constant regions of immunoglobulins switch from IgM 
to IgG, IgA or IgE. Immunoglobulins, or antibodies, play a cru-
cial role in immune response through their effector functions. 
CSR is initiated by activation-induced cytidine deaminase 
(AID). In repetitive switch regions of Igh gene, AID deami-
nates deoxycytidine resulting in deoxyuracil (dC > dU). The 
dUs are excised by the uracil DNA N-glycosylase (UNG) en-
zyme, leaving an abasic (apyrimidinic/apurinic [AP]) site.27 
The AP sites are cut by AP endonuclease (APE)1 or APE2, 
producing DNA single-strand breaks (SSB). Two SSBs on 
the opposite DNA strands form DSBs, initiating the CSR.27 
The joining of DSBs during the CSR is performed both by 
the classical NHEJ (C-NHEJ) and alternative end joining (A-
EJ).28 Strikingly, the A-EJ can maintain up to 50% of CSR 
activity in the absence of core C-NHEJ factors, such as Ku70, 
XRCC4, Lig4 and XLF.1
Other proteins, such as members of the DNA polymerase 
X family and terminal deoxynucleotidyl transferase enzyme 
(TdT), can also be involved in C-NHEJ within B cells.29,30 
For example, DNA polymerase proteins Pol λ and Pol μ 
promote DNA end joining through the processing of DSBs, 
while TdT increases the antibody and TCR repertoire by add-
ing non-template nucleotides prior to ligation of DNA ends 
during V(D)J recombination.29,30 Proteins such as nipped-B-
like protein (NIPBL) and breast cancer 1 (BRCA1) have also 
been shown to play a role in NHEJ.31,32
2 |  NON-HOMOLOGOUS END-
JOINING–DEFICIENT MICE
Before transgenic mice became popular, an inbred strain of 
immunodeficient mice with severe combined immunodefi-
ciency (SCID) was identified.33 First characterized by Bosma 
et al,33 SCID mice carry a recessive mutation in the Dna-
pkcs gene, which results in impaired V(D)J recombination 
and a subsequent lack of mature B and T lymphocytes in 
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homozygous mice. Later, transgenic mouse models deficient 
for Dna-pkcs gene were generated by several groups.13-16 
DNA-PKcs–deficient mice (Dna-pkcs−/−) are live-born and 
possess a SCID phenotype due to inefficient coding-end 
(CE) joining during the V(D)J recombination13 (Figure  1). 
Artemis−/− mice have also been observed to exhibit a SCID 
phenotype due to lack of CE joining.17 Thus, both DNA-PKcs 
and Artemis are required for processing of RAG-mediated 
hairpin-sealed DNA ends (CEs) during V(D)J recombination, 
although repair of blunt signal ends (SEs) remains efficient 
in mice lacking Artemis17 or DNA-PKcs.13-15 Inactivation of 
Ku7011 or Ku8010 in mice results in reduced body weight and 
a SCID phenotype. Lack of B and T lymphocytes in Ku70−/− 
and Ku80−/− mice is explained by inefficient joining of both 
RAG-induced blunt SEs and hairpin-sealed CEs.10,11
In contrast, inactivation of Lig48 or Xrcc49 results in em-
bryonic lethality in mice, presenting challenges for in vivo 
studies. However, cell studies show that inactivation of Lig4 
or Xrcc4 led to inefficient joining of both SEs and CEs, re-
sembling Ku-deficient phenotypes in mice. This suggests that 
such in vivo models would yield an immunodeficient animal 
due to ablated V(D)J recombination and lack of B and T cells, 
if one could be generated.8,9
Several single-deficient mouse models initially suggested 
that XLF, PAXX and MRI are dispensable for the V(D)J re-
combination. Particularly, mice lacking XLF/Cernunnos34,35 
possess both mature B and T cells, despite being character-
ized by modest lymphocytopenia, and reduced repertoires 
of B cell receptors and TCRs.34,35 Xlf−/− lymphocytes sup-
port efficient V(D)J recombination in vitro, including both 
SE and CE repair.34,35 Mice lacking either PAXX18,19,21,36 or 
MRI22,23 possess normal counts of mature B and T cells, ef-
ficiently supporting both SE and CE repair during the V(D)J 
recombination. However, more complex mouse models have 
revealed that XLF, PAXX and MRI are required for V(D)J 
recombination, although their functions are compensated by 
each other and additional proteins due to the extensive ge-
netic interaction inside the NHEJ pathway, as well as interac-
tion between the NHEJ and DDR pathways.1,37
Xlf−/−34,35 and Dna-pkcs−/−13 mice show notable radio-
sensitivity, but result in viable mice. However, double-defi-
cient Xlf−/−Dna-pkcs−/− mice are characterized by perinatal 
lethality and increased genomic instability, due to nearly no 
NHEJ.38 While lymphocytes lacking either XLF or DNA-PKcs 
are capable of repairing RAG-induced blunt SEs, Xlf−/−Dna-
pkcs−/− cells are unable to join SEs.38 Embryonic lethality of 
Xlf−/−Dna-pkcs−/− mice is p53- and Ku-dependent, and triple-de-
ficient Xlf−/−Dna-pkcs−/−Trp53+/−39,40 and Ku70−/−Xlf−/−Dna-
pkcs−/−40 mice are live-born, although they possess reduced 
body weight comparable to one of Ku70−/− mice.39,40
Xlf−/−Dna-pkcs−/− was the first mouse model that high-
lighted genetic interaction between Xlf and accessory 
F I G U R E  1  Genetic interactions between the NHEJ factors in mice. The phenotypes of mice are indicated. Genetic interactions are marked as 
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NHEJ factors in vivo (Figure  1). Mice lacking both XLF 
and Artemis are live-born, are fertile and have a SCID 
phenotype resembling single-deficient Artemis−/− mice,38 
suggesting no genetic interaction between Xlf and Artemis 
in vivo. Later, genetic interaction between Xlf and Paxx 
was characterized in vivo independently by four research 
groups.18,19,36,39 Mice lacking both XLF and PAXX pos-
sess late embryonic lethality, increased genomic instabil-
ity and immunodeficiency; and Xlf−/−Paxx−/− lymphocytes 
are unable to sustain repair of both SEs and CEs generated 
during V(D)J recombination.18,19,36,41 The embryonic le-
thality of Xlf−/−Paxx−/− mice is p53-dependent, and both 
Xlf−/−Paxx−/−Trp53+/− and Xlf−/−Paxx−/−Trp53−/− mice are 
live-born, but possess significant weight reduction and 
a leaky SCID phenotype with nearly no mature B and T 
lymphocytes.39,42
Furthermore, Xlf−/−Mri−/− double knockout mice are em-
bryonic lethal,23 but can be rescued by inactivation of one 
or two alleles of Trp53.42 Mice lacking both XLF and MRI 
are characterized by leaky SCID with nearly no mature B 
and T lymphocytes due to the V(D)J recombination defect.23 
In particular, the lymphocytes lacking both XLF and MRI 
are unable to efficiently ligate both RAG-mediated SEs and 
CEs in vitro.23 Both the double-deficient mouse model lack-
ing XLF and PAXX and the model lacking XLF and MRI 
are characterized by leaky SCID with low but detectable 
levels of mature B and T lymphocytes.42 This phenotype is 
likely possible due to residual NHEJ activity in developing 
Xlf−/−Paxx−/− and Xlf−/−Mri−/− lymphocytes in vivo.39,42
Thus, there is evidence that Xlf genetically interacts with 
Dna-pkcs,38-40 Paxx18,19,36,39,42 and Mri.23,42 Further trans-
genic mouse studies address whether Dna-pkcs genetically 
interacts with Paxx and Mri, and whether Paxx genetically 
interacts with Mri. Dna-pkcs−/−Paxx−/− mice are live-born, 
fertile and indistinguishable from Dna-pkcs−/− littermates.39 
Furthermore, Mri−/−Paxx−/− mice possess nearly no de-
tectable phenotype, similar to single-deficient Mri−/− and 
Paxx−/− mice.42 In contrast, Dna-pkcs−/−Mri−/− mice are 
embryonic lethal.42 Therefore, there is no genetic interaction 
between Dna-pkcs and Paxx, or Mri and Paxx; however, Dna-
pkcs and Mri interact genetically (Figure 1).
Inactivation of Ku, Trp53 or Atm rescues embryonic le-
thality of Lig4−/− mice. In particular, Ku80−/−Lig4−/−43 
and Ku70−/−Lig4−/−44 mice are not distinguishable from 
Ku-deficient mice, possessing reduced body weight, in-
creased levels of genomic instability and a SCID phenotype. 
Furthermore, Lig4−/−Trp53+/− and Lig4−/−Trp53−/− mice, 
although live-born, possess reduced body weight, increased 
levels of genomic instability and SCID due to inability to re-
pair SEs and CEs during V(D)J recombination.45 Moreover, 
Lig4−/−Trp53+/− mice present a more severe phenotype than 
Lig4−/−Trp53−/− littermates, likely due to an incomplete 
block of DNA damage-induced apoptosis in the presence of 
one Trp53 allele.45 In addition, inactivation of one or two al-
leles of Atm rescued lethality in Lig4-deficient mice.46 Both 
Lig4−/−Atm+/− and Lig4−/−Atm−/− mice displayed impairment 
in lymphocytic development, growth retardation and short 
lifespan (up to 2 days postnatally).46 Further, inactivation of 
one or two alleles of Trp53 rescues embryonic lethality of 
Xrcc4−/− mice.47 The Xrcc4−/−Trp53+/− mice possess a more 
severe phenotype when compared to the Xrcc4−/−Trp53−/− 
littermates, although both models are characterized by re-
duced body weight, increased genomic instability and SCID 
due to inability to repair RAG-induced DSBs in developing 
B and T cells.47
Several complex mouse models have also revealed a 
lack of genetic interaction between different pairs of NHEJ 
genes (Figure 1). In particular, mice lacking Ku80 and either 
XLF (Ku80−/−Xlf−/−), PAXX (Ku80−/−Paxx−/−)19 or DNA-
PKcs (Ku80−/−Dna-pkcs−/−)48 are indistinguishable from 
Ku80−/− mice, whereas Ku70−/−Xlf−/− and Ku70−/−Dna-
pkcs−/− mice are indistinguishable from Ku70−/− litter-
mates.40 Finally, embryonic lethality of Lig4−/− mice is not 
rescued by the inactivation of Paxx−/− (Lig4−/−Paxx−/−)19 
(Figure 1).
2.1 | Class switch recombination
Class switch recombination occurs in mature B cells fol-
lowing the efficient V(D)J recombination in vivo. However, 
several experimental models allow for the bypass of V(D)
J recombination to determine the impact of specific factors 
on CSR, even though these factors are required for earlier 
stages of B cell development (e.g., Artemis, DNA-PKcs). 
Knocking-in pre-assembled heavy and light chains of the 
immunoglobulin gene (‘HL’) allows for the development 
of mature B cells in mice that otherwise lack the capacity 
for V(D)J recombination.49 For example, lack of Artemis or 
DNA-PKcs49 moderately affects the CSR in mature B cells. 
Additionally, it was found that CSR levels were reduced 
two- to threefold in cells lacking XLF,34,35 Ku70,44 Ku80,44 
Lig428 or XRCC4.28 PAXX seems to be dispensable for CSR 
in wild-type cells,18,19,21,36,50 while inactivation of Mri results 
in modest CSR defects.22,23,42
DNA-PKcs and XLF are functionally redundant 
in CSR.38 PAXX is also functionally redundant with 
XLF (Xlf−/−Paxx−/− cell lines),51 but not with MRI 
(Mri−/−Paxx−/− mice).42
2.2 | Genetic interaction between NHEJ and 
DDR factors
DNA damage response factors genetically interact with 
NHEJ components. Atm is synthetically lethal with Ku70 
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(Atm−/−Ku70−/−), Ku80 (Atm−/−Ku80−/−) and Dna-pkcs 
(Atm−/−Dna-pkcs−/−)46 (Figure 2). Combined inactivation of 
Atm and Dna-pkcs in cells results in more severe CSR defects 
than in single-deficient controls.52 Moreover, Atm−/−Dna-
pkcs−/− pro-B cells lack repair of both SEs and CEs during 
the attempted V(D)J recombination.53
Furthermore, Xlf genetically interacts with Atm, 53bp1, 
H2ax and Mdc1.37,54-56 In particular, mice lacking XLF and 
ATM (Xlf−/−Atm−/−) are live-born, possess reduced body 
weight and CSR, increased genomic instability and lack of 
V(D)J recombination in developing B and T cells, resulting 
in severe lymphocytopenia (Figure  2).1,54 Xlf−/−53bp1−/− 
mice are live-born, possess reduced body weight, increased 
genomic instability and reduced B and T cell count due to 
the block in V(D)J recombination in developing lymphocytes 
(Figure 2).55,56 Synthetic lethality does arise with Xlf and H2ax 
as well as Xlf and Mdc1 in mice, and double-deficient pre-B 
cells, Xlf−/−H2ax−/− and Xlf−/−Mdc1−/−, possess reduced ef-
ficiency of V(D)J recombination.37,54 Finally, Atm does not 
interact genetically with Paxx and Mri. Atm−/−Paxx−/− cells 
possess DNA repair levels similar to single-deficient con-
trols,19,41,57 while Atm−/−Mri−/− mice are indistinguishable 
from Atm−/− littermates23 (Figure  2). Taken together, evi-
dence shows that Atm genetically interacts with Ku70, Ku80, 
Dna-pkcs and Xlf, but not with Paxx or Mri. Correspondingly, 
Xlf genetically interacts with Atm, H2ax, Mdc1 and 53bp1.
2.3 | Genetic interaction between 
Xlf and Rag
Xlf has also been shown to genetically interact with Rag2.58 
Mutation in the Rag2 gene results in the truncated protein 
‘core Rag2’, which continues to support DSB formation and 
DNA repair in developing B and T lymphocytes. However, 
in XLF-deficient cells, this ‘core Rag2’ activity is lost, and 
V(D)J recombination does not proceed. This finding suggests 
a potential role for RAG in both the induction of DSBs and 
DNA repair, as the RAG complex supports tethering of DNA 
ends before ligation58 (Figure 2).
2.4 | Neuronal phenotype of NHEJ-
deficient mice
Genomic instability in NHEJ-deficient mice gives rise to in-
creased cell death in the central nervous system (CNS), in-
cluding the brain, which correlates with embryonic lethality 
(Figure 1). XRCC4-deficient mice exhibit massive post-mi-
totic neuronal apoptosis with severe acellularity in the inter-
mediate zone in the neocortex.9,47 Similarly, Lig4-deficient 
mice also exhibit apoptosis of post-mitotic neurons.8 While 
Ku70−/− mice are live-born, they possess modestly increased 
levels of neuronal cell death, which is nevertheless lower 
than that in Xrcc4−/− or Lig4−/− mice.11,43,59 Inactivation 
of Trp53 in Xrcc4−/− (Xrcc4−/−Trp53−/−) and Lig4−/− mice 
(Lig4−/−Trp53−/−) significantly reduces neuronal apoptosis 
in the cortex,45,47 similar to what is reported in Lig4−/−Atm−/− 
mice.46 Inactivation of Ku80 rescues the lethality of Lig4−/− 
mice,43 and brains from Lig4−/−Ku80−/− mice are similar to 
those from Ku80−/− mice.43 XLF-deficient mice show no 
neuronal defects,34,35 although mutations in human XLF are 
associated with microcephaly.12
Single deficiency for Dna-pkcs,9,59 Paxx18,19,21,36 or 
Mri22,23 results in mice with no obvious neurological defects. 
However, mice that are homozygous for Dna-pkcs with point 
mutation D3922A (kinase dead, Dna-pkcsKD/KD) possess 
p53- and Ku-dependent embryonic lethality, as well as in-
creased neuronal apoptosis, with an overall phenotype resem-
bling Xrcc4−/− and Lig4−/− mice.60
Strikingly, combined deficiency for XLF and PAXX 
(Xlf−/−Paxx−/−),18,19,36 and XLF and MRI (Xlf−/−Mri−/−)23 
results in synthetic lethality, which correlates with massive 
neuronal apoptosis in the neocortex.
Hence, deficiencies in NHEJ often result in neuronal apopto-
sis, likely due to accumulation of DSBs in post-mitotic neurons. 
F I G U R E  2  Genetic interactions 
between NHEJ factors, DDR factors and 
Rag2 in mice. The phenotypes of mice are 
indicated. Genetic interactions are marked 
as √. The lack of interaction is marked as ×
Rag2 SCID
53bp1 SCID, Size ↓
Mdc1 Lethal
H2ax Lethal
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Inactivation of p53 prevents neuronal apoptosis, for example, 
by allowing A-EJ to repair DSBs in NHEJ-deficient cells.
2.5 | NHEJ in mouse and human
Mutations in several NHEJ genes have been identified in 
humans.61,62 For instance, patients with mutations in XLF, 
DNA-PKCS/PRKDC and LIG4 genes display severe clinical 
features, characterized mainly by SCID, delayed growth and 
neurological abnormalities.61,62 In mice, XLF deficiencies 
lead to a modest lymphocytopenia and defect in CSR34,35; 
DNA-PKcs deficiencies lead to a SCID phenotype but no 
neural complications59; and Lig4-deficiencies are embryonic 
lethal.8 In the same manner, ARTEMIS/DCLRE1C-deficient 
patients are characterized by SCID but not neurological de-
fects62; similar to Artemis-deficient mice.17 On the other 
hand, Xrcc4−/− mice are embryonic lethal,9 unlike XRCC4-
deficient patients who only display neurological problems.63 
Mutations in several NHEJ genes have not yet been found 
in human immunodeficient patients up to the present. These 
genes include Ku70, Ku80, PAXX and MRI. Ku70 and Ku80 
might be essential in human cells, and therefore, mutations 
in KU70 and KU80 genes might be identified only by ana-
lysing embryonic samples. However, mutations in accessory 
factor genes PAXX and MRI might present without clinical 
features, based on the knowledge we have obtained from 
mouse models.18,19,21-23,36 In the latter case, XLF might com-
pensate for deficiencies in PAXX and MRI in human cells. 
Sometimes, dramatic differences in phenotypic presentation 
between mice and humans lacking the same NHEJ factor 
can be explained, for example, by minor sequence changes 
between species, resulting in significant changes in protein-
protein and protein-DNA interactions, and inability for other 
factors to compensate the protein loss.
2.6 | Potential reasons for genetic 
interactions between the NHEJ factors
There are several types of genetic interaction between the 
DNA repair factors and several potential explanations for 
them, although detailed mechanisms have not been eluci-
dated yet.
Why does inactivation of Ku7011 or Ku8010 result in via-
ble mice, while inactivation of Lig48 or Xrcc49 results in em-
bryonic lethality? This cannot simply be due to lack of NHEJ 
activity, because cells lacking any of these factors are char-
acterized by similar genomic instability.38,40,57 The Ku70/
Ku80 complex seems to be toxic for the cells when the NHEJ 
pathway is blocked due to defects in downstream factors. It 
is possible that Ku may block access to DSB sites from other 
DNA repair pathway proteins, preventing DNA ligation and 
eventually resulting in the accumulation of DSBs, activation 
of p53 and apoptosis. Interestingly, Ku-deficient cells rely on 
other DNA repair pathways, such as homologous recombi-
nation and alternative end joining. This could also explain 
why inactivation of Ku70 or Ku80 rescues embryonic lethal-
ity of Lig4−/− mice.43,46 Similarly, lack of Ku rescues embry-
onic lethality in mice lacking XLF/DNA-PKcs,38,40 as well 
as in mice with an inactivating DNA-PKcs point mutation.60 
Following the same logic, one can predict that inactivation 
of Ku70 or Ku80 would also have the ability to rescue syn-
thetic lethality between Xlf and Paxx, and between Xlf and 
Mri. We can also predict that inactivation of all NHEJ genes 
in a mouse would result in a phenotype similar to those of 
Ku70−/− or Ku80−/− mice,22 and suggest that all NHEJ genes 
function in a purely Ku-dependent manner.
Synthetic lethality between Xlf and Dna-pkcs,38-40 Xlf and 
Paxx18,19,36,39,42 and Xlf and Mri23,42 results in phenotypes 
similar to Lig4−/− and XRCC4−/−. In all these cases, it is likely 
that the DNA ligation step is impaired, while Ku70/Ku80 re-
mains functional. There are several potential explanations for 
the functional redundancy observed between XLF and other 
factors in NHEJ and DDR.1,38,54,56 First, XLF and the second 
factor could have identical functions, such as having a role in 
stabilizing the DNA repair complex. A second explanation 
could be that XLF and the second factor could have purely 
complementary functions; for example, one protein stimu-
lates DNA ligation while another one is required for DNA 
end tethering. However, the question of XLF’s functionally 
redundancy with so many other factors1,18,19,23,36,38-40,42,54 is 
still an enigma in the field of DNA repair.
ATM and DNA-PKcs are both protein kinases. Synthetic 
lethality between Atm and Dna-pkcs46 is reasonable to pre-
dict because these two proteins can partially compensate 
for each other’s activity when one is inhibited, but no other 
protein can compensate combined ATM/DNA-PKcs defi-
ciency.52,53,64 DNA-PKcs is part of the DNA-PK holoen-
zyme, which includes Ku70 and Ku80. Both Ku70 and Ku80 
are synthetic lethal with Atm,46 meaning that ATM is func-
tionally redundant with the Ku70/Ku80/DNA-PKcs com-
plex, and DNA-PKcs will likely be inactive in cells lacking 
Ku70 or Ku80.
Deficiency in Atm partially rescues lethality of mice 
lacking Lig4.46 This may be related to the function of ATM, 
which translates critical accumulation of DSBs to apopto-
sis via CHK1, CHK2 and p53. Similarly, inactivation of 
one or both alleles of Trp53 (encoding for p53) rescues 
embryonic lethality of Lig4−/−,45 Xrcc4−/−,47 Xlf−/−Dna-
pkcs−/−,39,40 Xlf−/−Paxx−/−39,42 and Xlf−/−Mri−/−42 mice. We 
can infer that the dose-dependent reduction of apoptosis 
from ATM and p53 deficiency could ensure survival for 
NHEJ-deficient mice lacking DNA ligation capabilities, 
albeit these alterations would likely lead to tumorigenesis 
and cancer.39,40,42,45-47
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Overall, there are complex genetic interactions between 
the genes of the NHEJ pathway, and between NHEJ and DDR 
factors. Genetically modified mouse models and murine cell 
lines have helped to uncover specific functions of DNA repair 
factors previously hidden due to the functional redundancy. 
Further studies will uncover additional genetic interactions 
between the DNA repair factors and pathways. Only a portion 
of genetic interaction is analysed today, and empty cells rep-
resent potential future studies (Figures 1 and 2).
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